APOE and Alzheimer disease: For instance with those criteria, in the Australian Imaging Biomarkers and Lifestyle Study of Aging (AIBL), often used to validate findings on ADNI, the AD cohort only contains 38 patients with a total 105 visits, and the healthy cohort 128 patients with 431 visits, before the additional stratification by sex or APOE-ε4 genotype.